Global shortage of two key treatments
Manx Care says there’s 'no immediate threat' to stroke patients, and those with heart conditions, due to a global shortage of two key treatments.
The Isle of Man, along with UK NHS trusts, is being asked to conserve supplies of two drugs - Alteplase and Tenecteplase - due to manufacturer issues.
The shortage is expected to last until early next year and hospitals are being asked to provide alternative treatments where appropriate.
Dr Sreeman Andole is the executive medical director, and stroke consultant, at Noble's Hospital:
Teresa Cope 'an extraordinarily dedicated public servant' who wasn't pushed out of job, says Manx Care chair
Ramsey Minor Injuries Unit to reopen next week
Local pharmacist believes gap to GP's is "narrowing"
Young farmer hopes to shine light on mental health
Manx Care: Hospital pressures beginning to ease after OPEL 4 escalation